Best Japanese Companies To Buy Right Now

Last week, shares of Ford Motor (NYSE: F  ) crossed the $15 line for the first time since early 2011. The last time Ford stock reached that level, the company was benefiting from a spate of recalls at Toyota Motor (NYSE: TM  ) and the devastating Japanese tsunami of March 2011, which disrupted supplies for Toyota, Honda Motor (NYSE: HMC  ) , and other Japanese automakers.

Today, Ford stock's strength can be attributed to the company's success, rather than competitors' difficulties. The U.S. housing market recovery has boosted demand for Ford's F-Series pickups. Meanwhile, high fuel prices have encouraged U.S. consumers to replace their aging cars with more fuel-efficient models. Lastly, international trends are improving: Ford is gaining market share in China -- the world's largest auto market -- and is implementing a decisive plan to return to profitability in Europe.

Best Japanese Companies To Buy Right Now: King Solomon Mines Ltd (KSO.AX)

King Solomon Mines Limited, through its subsidiaries, engages in the acquisition, exploration, and development of mineral resource properties in China. It primarily explores for gold, copper, and other metallic deposits. The company�s properties located in the Sonid Zuoqi county, Inner Mongolia include the Marmot copper�molybdenum�gold project that covers an area of 39.7 square kilometers; Sonid North gold project covering an area of 24.8 square kilometers; and Naogaoshandu gold project, which covers an area of 47.2 square kilometers. It also holds interest in Bu Dun Hua porphyry copper�molybdenum project covering an area of 25.1 square kilometers in the Wengniute County, Inner Mongolia. The company was founded in 2003 and is based in Auckland, New Zealand.

Best Japanese Companies To Buy Right Now: Kforce Inc.(KFRC)

Kforce Inc., together with its subsidiaries, provides professional and technical staffing services and solutions in the United States. It operates in five segments: Technology, Finance and Accounting, Clinical Research, Health Information Management, and Government Solutions. The Technology segment offers temporary staffing and permanent placement services to its clients, focusing on information technology comprising systems/applications programmers and developers, senior-level project managers, systems analysts, enterprise data management, e-business, and networking technicians, as well as healthcare, financial services, and government integrators. The Finance and Accounting segment provides temporary staffing and permanent placement services to its customers in taxation, budget preparation and analysis, mortgage and loan processing, financial reporting, cost analysis, accounts payable, accounts receivable, professional administrative, credit and collections, general acco unting, audit services, and systems and controls analysis and documentation. The Clinical Research segment is involved in providing functional outsourcing solutions for monitoring clinical research site, contingent contract staffing, and permanent placement of clinical research personnel to pharmaceutical and biotechnology companies. The Health Information Management segment offers temporary staffing and permanent placement services to its clients consisting of acute care facilities, physician clinics, software providers, and insurance companies, as well as in medical coding, the revenue life cycle, and health information technology areas. The Government Solutions segment provides technology, and finance and accounting professionals to the federal government; and integrated business solutions in the information technology, data and knowledge management, research and development, financial management, and accounting areas. Kforce Inc. was founded in 1994 and is headquartered in Tampa, Florida.

Top Promising Stocks To Buy For 2014: West Street Capital Corp. (WSC.V)

West Street Capital Corporation operates as an investment holding company. It holds an investment portfolio consisting of preferred share and debenture investments in various Canadian and foreign corporations. The company was incorporated in 1984. It was formerly known as Consolidated Enfield Corporation and changed its name to West Street Capital Corporation in May 2004. West Street Capital Corporation is based in Toronto, Canada.

Best Japanese Companies To Buy Right Now: Quest Diagnostics Inc (DGX)

Quest Diagnostics Incorporated (Quest Diagnostics), incorporated in 1990, is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. Quest Diagnostics offers United States patients and physicians the access to diagnostic testing services through its nationwide network of laboratories and Company-owned patient service centers. The Company provides interpretive consultation through the medical and scientific staff. The Company is a provider of clinical testing, including gene-based and esoteric testing and anatomic pathology services, and the provider of risk assessment services for the life insurance industry. The Company also is a provider of testing for clinical trials and testing for drugs of abuse. Its diagnostics products business manufactures and markets diagnostic test kits and specialized point-of-care testing. On April 4, 2011, the Company acquired Athena Diagnostics (Athena). On May 17, 2011, the Company acquired Celera Corporation (Celera). In January 2012, the Company acquired S.E.D. Medical Laboratories. In December 2012, the Company sold all of the assets of OralDNA Labs salivary-diagnostics business to Access Genetics. Quest Diagnostics Incorporated (Quest Diagnostics) is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. Quest Diagnostics offers United States patients and physicians the access to diagnostic testing services through its nationwide network of laboratories and Company-owned patient service centers. The Company provides interpretive consultation through the medical and scientific staff. The Company is a provider of clinical testing and the provider of risk assessment services for the life insurance industry. The Company also is a provider of testing for clinical trials and testing for drugs of abuse. In January 2012, it acquired S.E.D. Medical Laboratories. In December 2012, it sold all of the ! assets of OralDNA Labs salivary-diagnostics business to Access Genetics. In January 2013, the Company acquired the Worcester -based clinical outreach laboratory business of UMass Memorial Medical Center.

Clinical Testing

The Company is a commercial clinical testing company. Physicians use clinical tests to assist in the detection, diagnosis, evaluation, monitoring and treatment of diseases and other medical conditions. Clinical testing is generally categorized as clinical laboratory testing and anatomic pathology services. The Company offers customers the access to the test menu of clinical laboratory and anatomic pathology tests in the United States. Clinical laboratory testing generally is performed on whole blood, serum, plasma and other body fluids, such as urine, and specimens such as microbiology samples.

The Company is a provider of routine clinical testing, including testing for drugs of abuse. The Company performs routine testing through its network of laboratories and rapid response laboratories. The Company also performs routine testing at hospital laboratories that the Company manages. The Company operates laboratories round the clock. The majority of test results are delivered electronically. Routine tests measure various bodily health parameters, such as the functions of the kidney, heart, liver, thyroid and other organs. Commonly ordered tests include blood chemistries, including cholesterol levels; complete blood cell counts; urinalysis; pregnancy and other prenatal tests, and routine microbiology testing.

The Company is a provider of anatomic pathology services in the United States, through its AmeriPath, Dermpath Diagnostics and Quest Diagnostics brands. Anatomic pathology involves the diagnosis of cancer and other diseases and medical conditions through examination of tissue and cell samples taken from patients. The Company provides inpatient anatomic pathology and medical director services at hospitals throughout the country, and through ! its labor! atories. The Company provides a range of services to all anatomic pathology subspecialties. The Company provides integrated, reports that include both anatomic pathology and clinical pathology tests, enabling its pathologists to offer patients and physicians a complete analysis. The Company introduced the Leumeta family of tests for leukemia and lymphoma.

The Company is a provider in the United States of gene-based and esoteric testing. Esoteric tests include procedures in the areas of molecular diagnostics, protein chemistry, cellular immunology and advanced microbiology. Commonly ordered esoteric tests include viral and bacterial detection tests, drug therapy monitoring tests, genetic tests, autoimmune panels and complex cancer evaluations. During the year ended December 31, 2011, it acquired Athena Diagnostics, a provider of neurology testing. Its esoteric laboratories provide reference testing services to physicians, academic medical centers, hospitals and other commercial laboratories. The Company also offers gene-based tests for the predisposition, diagnosis, treatment and monitoring of cancers. The Company develops tests at its laboratories, such as Quest Diagnostics Nichols Institute. It also develops techniques and services in anatomic pathology.

In 2011, the Company introduced its melanoma treatment selection mutation panel, which is designed to assist in the personalized selection of patient therapies. The Company introduced its thyroid cancer mutation panel, which assists in the diagnosis of thyroid cancer and aids physicians and surgeons as they plan surgery and other therapies to treat and attempt to cure thyroid cancer. During 2011, it enhanced its SureSwab Vaginosis/Vaginitis Plus test. The Company introduced Accutype IL28b, a test designed to aid in the prediction of patient response to peginterferon alpha-based therapy for treating hepatitis C virus infection. In 2011, it introduced testing for very long chain fatty acids, to assist in diagnosis and monitori! ng of inh! erited disorders of fatty acid metabolism. It also introduced high resolution chromosomal analysis testing with oligonucleotide microarrays to enhance its testing services in the pre-natal and post-natal genetics areas. During 2011, the Company released a test for therapeutic drug monitoring of dabigatran, an oral anti-coagulant. The Company also released genetic testing for SLC01B1, which helps identify patients at risk for myopathy from Simvastatin therapy for cholesterol reduction. Through Athena Diagnostics, it launched several molecular genetic tests for stroke, neuromuscular diseases and mitochondrial disorders.

Healthcare Information Technology

The Company provides interoperable technologies that help healthcare organizations and physicians enter, share and access clinical information without costly information technology (IT) implementation or workflow disruption, including through its Care360 suite of products and its ChartMaxx electronic document management system for hospitals. These solutions offer access to a national healthcare provider network, including approximately 200,000 networked physicians and clinicians using Quest Diagnostics��Care360 connectivity products. The Care360 products, including its Care360 Labs and Meds, enable physicians electronically to order diagnostic tests and review test results from Quest Diagnostics and electronically to prescribe medication. As of December 31, 2011, prescriptions were written through Care360 ePrescribing at an annualized rate of 32 million medications. Using its Care360 connectivity products, physicians can securely provide diagnostic and other data to a patient�� account. It offers Gazelle, a secure mobile health platform that allows users to receive their Quest Diagnostics laboratory results, manage their personal health information, find a Quest Diagnostics location and schedule appointments directly from their smartphone.

Clinical Trials Testing

The Company is a provider of central l! aboratory! testing performed in connection with clinical research trials on new drugs, vaccines and certain medical devices. It has clinical trials testing centers in the United States and the United Kingdom, and it provides clinical trials testing in Argentina, Australia, Brazil, the People�� Republic of China and Singapore through affiliated laboratories. The Company has biomarker capabilities. In 2011, it acquired Celera, enhancing its ability to provide biomarker discovery and develop IVD test kits.

Life Insurer Services

The Company is a provider of risk assessment services to the life insurance industry in North America. It also provides risk assessment services for insurance companies doing business in many countries outside the United States. Its risk assessment services comprise underwriting support services to the life insurance industry, including laboratory testing, electronic data collection, specimen collection and paramedical examinations, medical record retrieval, case management, motor vehicle reports, telephone inspections, prescription histories and credit checks. The laboratory tests that it performs and data it gathers are designed to assist insurance companies to objectively evaluate the mortality risks of policy applicants. The majority of the testing is performed on specimens of life insurance applicants, but also includes specimens of applicants for other types of insurance. Most of its specimen collections and paramedical examinations are performed by its network of approximately 5,000 contracted paramedical examiners at the applicant�� home or workplace. The Company also offers paramedical examinations through approximately 500 of its patient service centers, and operate approximately 80 locations other than patient service centers in the United States and Canada where the Company provides paramedical examinations, bringing to approximately 580 the total number of sites where it can provide these examinations. The Company also contracts with third parties at over! an addit! ional 200 locations globally to coordinate providing these exams.

Employer Services

The Company is a provider of testing to employers for the detection of employee use of drugs of abuse. Its Quest Diagnostics Drug Testing Index, which is an annual report of its aggregate drug testing results, is used by employers, the federal government and the media to help identify and quantify drug abuse among the nation�� workforce. It provides a range of solutions for drugs of abuse, including urine, hair, blood and oral fluid tests. In 2011, it introduced Oral-Eze, its own oral fluid collection system that simplifies the collection of oral samples for routine drug testing. The Oral-Eze Oral Fluid Collector provides all the advantages of previous collection systems, with the added benefit of its indicator window technology. The Company provides wellness testing and analytic services to employers.

Diagnostic Products

Diagnostic Products include point-of-care, or near-patient and testing. The Company develops and manufactures products that enable healthcare professionals to make healthcare diagnoses, including products for point-of-care, or near-patient, testing for the professional market. The Company has several companies, including Focus Diagnostics, HemoCue and Celera. Focus Diagnostics is a provider of infectious disease testing. Focus Diagnostics develops, manufactures and markets diagnostic products, such as HerpeSelect ELISA tests that detect patient antibodies to specific types of herpes simplex virus, which can be performed on a variety of instrument platforms. Focus Diagnostics sells its diagnostic products to academic medical centers, hospitals and commercial laboratories globally. Focus Diagnostics has an agreement with 3M Corporation for global human diagnostic rights to a compact integrated bench-top instrument for use with real time polymerase chain reaction (PCR) assays. These tests are sold under the Simplexa brand name. In 2011, Focus Diagnostic! s receive! d the CE mark to offer Simplexa tests in Europe, including tests for Cytomegalovirus, Epstein Barr virus, BK virus and clostridium difficile. Focus Diagnostics offers molecular transplant-testing menus in Europe.

HemoCue manufactures and distributes point-of-care testing products globally. HemoCue is a global provider in point-of-care testing for hemoglobin, with a growing market share for glucose, microalbumin and white blood cell testing. HemoCue offers its White Blood Cell Differential System in Europe. Celera offers complexity molecular diagnostic products in segments, such as HIV-1 drug resistance testing, reproductive genetics, transplantation and cardiovascular genetics. It also manufactures and offers the InSure fecal immunochemical test (FIT) for screening for colorectal cancer.

The Company competes with Laboratory Corporation of America Holdings, Inc.

Best Japanese Companies To Buy Right Now: General Communication Inc.(GNCMA)

General Communication, Inc. provides communication services to residential and business customers under the GCI and Alaska Wireless brand names in Alaska. The company?s Consumer segment provides local and long distance voice services; video services and products, including cable, high-definition television, digital video recorder, premium channel programming, video on demand, and pay-per-view programming services; Internet access; and fixed and mobile wireless voice and data services. This segment also sells handsets, personal computer wireless data cards, and accessories to residential customers; and offers bundled services and products, which comprise long-distance, cable television, cable modem Internet access, local access, and wireless services. Its Network Access segment provides interstate and intrastate-switched message telephone, multi-protocol label switching, frame relay, private line and dedicated Internet, and wireless services to GSM and CDMA wireless carrie rs. The company?s Commercial segment offers local and long distance communication, video, Internet, data network, managed, wireless, and bundled products and services. Its Managed Broadband segment offers Internet access, data network, and managed services to rural school districts, hospitals, and health clinics. The company?s Regulated Operations segment provides wireline communications services, including local access and long-distance, and Internet services and products, to residential, business, and governmental customers in areas of rural Alaska. General Communication, Inc. sells its services primarily through direct contact marketing, as well as through local media advertising, and its retail stores and Website. As of December 31, 2011, it had approximately 87,900 long-distance customers, 138,100 local access lines in service, 142,600 basic cable subscribers, 139,900 wireless subscribers, and 119,400 cable modem subscribers. The company was founded in 1979 and is bas ed in Anchorage, Alaska.

Best Japanese Companies To Buy Right Now: Surface Mount Tech (HLDGS)

Surface Mount Technology (Holdings) Limited, an investment holding company, provides electronic manufacturing services (EMS) for printed circuit board assembly. It offers EMS for various products, including computer peripherals, industrial controls, telecommunication, automotive electronics, office appliances, light-emitting diode lighting, digital audio video, and other consumer products. The company also trades in plant and machinery, and electronic component modules, as well as involves in property holding activities. It provides EMS and turnkey manufacturing services to original equipment manufacturers and original design manufacturers. The company sells its products and services in North America, the People�s Republic of China, and Europe, as well as in Asia, primarily Japan and Korea. Surface Mount Technology (Holdings) Limited was founded in 1986 and is based in Kwai Chung, Hong Kong.